Fitness guru and heart attack survivor amps up AZ campaign with meet-and-greets

Former Biggest Loser coach Bob Harper
Former "The Biggest Loser" host Bob Harper is hitting the road this summer in a extension of the AstraZeneca survivors' awareness campaign. (AstraZeneca)

Fitness coach and heart attack survivor Bob Harper told his story last year to inspire fellow heart patients to share their own. Now, the star of AstraZeneca’s “Survivors Have Heart” awareness push is hitting the road to meet other survivors in person.

AstraZeneca expanded the initial campaign to include in-person events with Harper after positive and inspiring feedback poured in last year. And the patients' stories spurred AZ to launch online, where heart attack survivors can discuss their journeys and vie for a chance to meet Harper at a local event. Harper's national tour kicked off in Tampa June 5.

For those who can’t attend an event, the new “Survivors Have Heart” Facebook community aims to help survivors share their personal stories and connect with one another. One of the key goals of the initial campaign, validated by patient feedback, was to raise awareness about the psychological impact of heart attacks.

Sept. 15-17,2020

Cytiva Virtual Event: Tapas & Tech Talks Copy - Strategies for robust and scalable

Strategies for robust and scalable processes: from research through late-stage trials
(with Cytiva and IQVIA)

RELATED: AstraZeneca taps Biggest Loser host Bob Harper for heart attack survivors push

“As we have heard from courageous survivors, the emotional journey can be sometimes even more challenging [than the initial physical recovery]," Alex Dyer, AstraZeneca's executive director of cardiovascular marketing, said via email.

"The cardiovascular risk for having another heart attack remains long after having the initial heart attack itself," Dyer noted, "so ‘Survivors Have Heart’ aims to offer heart attack survivors an inspiring and engaging community, so they don't have to go through this often overwhelming and sometimes isolating experience alone,”

RELATED: AstraZeneca's Brilinta wins in diabetic artery disease patients

AstraZeneca initially connected with Harper, a former host of “The Biggest Loser” TV show, after discovering that he'd been prescribed the company's clot-fighting drug Brilinta as part of his recovery plan.

AZ notched Brilinta sales of $1.3 billion in 2018, a 22% jump over 2017, and attributed (PDF) growth to continued penetration in acute coronary syndrome patients and high-risk heart attack survivors. More recently, Brilinta aced a combination study with aspirin in reducing the risk of heart attack, stroke and cardiovascular death in patients with Type 2 diabetes with coronary artery disease who hadn’t suffered prior heart attack or stroke.

Suggested Articles

Just one week after inking a COVID-19 vaccine deal with the U.S. for 100 million doses, J&J reached a supply agreement twice that size with the EU.

Ahead of a critical flu season, AstraZeneca is upping its manufacturing efforts to deliver more FluMist doses than previously anticipated.

FDA handed NS Pharma’s Viltepso a speedy FDA nod based on the same dystrophin production data that supported two Sarepta drugs' approvals.